Connectathon 11 Snapshot
This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
Mappings for the qicore-medication Profile.
| QICore-Medication | ||
| Medication | QICore-Medication | |
| id | ||
| meta | ||
| implicitRules | ||
| language | ||
| text | ||
| contained | ||
| extension | ||
| modifierExtension | ||
| code | ||
| isBrand | ||
| manufacturer | ||
| product | ||
| id | ||
| extension | ||
| modifierExtension | ||
| form | ||
| ingredient | ||
| id | ||
| extension | Medication.product.ingredient.isActiveIngredient | Not in QIDAM, but added because it was determined to be important for drug-allergy checking. For example, if the patient is allergic to Depakote (a trade name, and includes blue dye as an inactive ingredient), then when patient is prescribed warfarin, it shoots out a drug-allergy alert because warfarin also contains blue dye. Providers hate this. We recently overcame this problem by having the drug-allergy alert interaction settings only check for allergies to active ingredients. |
| modifierExtension | ||
| item | ||
| amount | ||
| batch | ||
| id | ||
| extension | ||
| modifierExtension | ||
| lotNumber | ||
| expirationDate | ||
| package | ||
| id | ||
| extension | ||
| modifierExtension | ||
| container | ||
| content | ||
| id | ||
| extension | ||
| modifierExtension | ||
| item | ||
| amount | ||
© HL7.org 2011+. FHIR DSTU2 (v1.2.0-7447) generated on Fri, Dec 11, 2015 17:44+1100.
Links: Search 
|
Version History |
Table of Contents |
Compare to DSTU1 |
|
Propose a change